PTPRD and head and neck cancer: For other patients (esophagogastric cancer, bladder cancer, head and neck cancer, colorectal cancer, and unknown primary), the median PFS of PTPRD mutation group was not different from WT (all p ≥0.05, Additional file 2: Fig. S10c-f).